Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F Jarrard

Showing results (91-100 of 132) with videos related to

Pageof 14
Sort By:
Cancer|June 10, 2011
Early hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrenceTim J Kruser, David F Jarrard, Andrew K Graf, et al.
Nature Biomedical Engineering|August 21, 2019
Reconfigurable open microfluidics for studying the spatiotemporal dynamics of paracrine signallingJiaquan Yu, Erwin Berthier, Alexandria Craig, et al.
Translational Oncology|May 4, 2018
Long Noncoding RNAs AC009014.3 and Newly Discovered XPLAID Differentiate Aggressive and Indolent Prostate CancersAnthony J Cesnik, Bing Yang, Andrew Truong, et al.
BJU International|May 3, 2017
Reduced estimated glomerular filtration rate (eGFR <60 mL/min/1.73 m<sup>2</sup> ) at first transurethral resection of bladder tumour is a significant predictor of subsequent recurrence and progressionMichael L Blute, Victor Kucherov, Timothy J Rushmer, et al.
Urology|September 27, 2016
Metastatic Tumor Burden Does Not Predict Overall Survival Following Cytoreductive Nephrectomy for Renal Cell Carcinoma: a Novel 3-Dimensional Volumetric AnalysisMichael L Blute, Timothy J Ziemlewicz, Joshua M Lang, et al.
Urologic Oncology|June 12, 2018
Effectiveness of a transrectal prostate needle biopsy protocol with risk-tailored antimicrobials in a veterans cohortKimberly A Maciolek, Sara L Best, Vania Lopez, et al.
Cancers|June 26, 2025
Statins Are Not Associated with Improved Bladder Cancer Outcomes in Patients with Early-Stage Bladder Cancer Treated with BCG ImmunotherapyEstelle Ndukwe, Paz Lotan, Michael Risk, et al.
Molecular Cancer Therapeutics|September 18, 2020
Synthetic Lethal Metabolic Targeting of Androgen-Deprived Prostate Cancer Cells with MetforminBing Yang, Shivashankar Damodaran, Tariq A Khemees, et al.
The Journal of Urology|April 4, 2015
Multi-Quadrant Biopsy Technique Improves Diagnostic Ability in Large Heterogeneous Renal MassesE Jason Abel, Jennifer E Heckman, Louis Hinshaw, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2025
Severe Late Toxicities (Grade 3-5) with 13 Years of Follow-up after Hypofractionated Postprostatectomy RadiotherapyKaili Ranta, Andrzej P Wojcieszynski, Shuang G Zhao, et al.
Pageof 14

Showing results (91-100 of 132) with videos related to

Sort By:
Pageof 14
Cancer|June 10, 2011
Early hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrenceTim J Kruser, David F Jarrard, Andrew K Graf, et al.
Nature Biomedical Engineering|August 21, 2019
Reconfigurable open microfluidics for studying the spatiotemporal dynamics of paracrine signallingJiaquan Yu, Erwin Berthier, Alexandria Craig, et al.
Translational Oncology|May 4, 2018
Long Noncoding RNAs AC009014.3 and Newly Discovered XPLAID Differentiate Aggressive and Indolent Prostate CancersAnthony J Cesnik, Bing Yang, Andrew Truong, et al.
BJU International|May 3, 2017
Reduced estimated glomerular filtration rate (eGFR <60 mL/min/1.73 m<sup>2</sup> ) at first transurethral resection of bladder tumour is a significant predictor of subsequent recurrence and progressionMichael L Blute, Victor Kucherov, Timothy J Rushmer, et al.
Urology|September 27, 2016
Metastatic Tumor Burden Does Not Predict Overall Survival Following Cytoreductive Nephrectomy for Renal Cell Carcinoma: a Novel 3-Dimensional Volumetric AnalysisMichael L Blute, Timothy J Ziemlewicz, Joshua M Lang, et al.
Urologic Oncology|June 12, 2018
Effectiveness of a transrectal prostate needle biopsy protocol with risk-tailored antimicrobials in a veterans cohortKimberly A Maciolek, Sara L Best, Vania Lopez, et al.
Cancers|June 26, 2025
Statins Are Not Associated with Improved Bladder Cancer Outcomes in Patients with Early-Stage Bladder Cancer Treated with BCG ImmunotherapyEstelle Ndukwe, Paz Lotan, Michael Risk, et al.
Molecular Cancer Therapeutics|September 18, 2020
Synthetic Lethal Metabolic Targeting of Androgen-Deprived Prostate Cancer Cells with MetforminBing Yang, Shivashankar Damodaran, Tariq A Khemees, et al.
The Journal of Urology|April 4, 2015
Multi-Quadrant Biopsy Technique Improves Diagnostic Ability in Large Heterogeneous Renal MassesE Jason Abel, Jennifer E Heckman, Louis Hinshaw, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2025
Severe Late Toxicities (Grade 3-5) with 13 Years of Follow-up after Hypofractionated Postprostatectomy RadiotherapyKaili Ranta, Andrzej P Wojcieszynski, Shuang G Zhao, et al.
Pageof 14